This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vitamin Shoppe, Inc. Sued By Investor

SAN DIEGO and NORTH BERGEN, N.J., May 10, 2013 /PRNewswire/ --  Shareholder rights attorneys at Robbins Arroyo LLP announce that a purchaser of Vitamin Shoppe, Inc. (NYSE: VSI) securities has filed a complaint in the U.S. District Court for the District of New Jersey.  The complaint alleges that Vitamin Shoppe and certain of its officers and directors violated the Securities Exchange Act of 1934 between May 8, 2012 and February 25, 2013 (the "Class Period"). 


Vitamin Shoppe Accused of Making False and Misleading Statements Concerning the Company's Business and Operations While Insiders Sell Their Stock

The complaint alleges that during the Class Period, Vitamin Shoppe and certain if its officers and directors issued a series of materially false and misleading statements concerning the true nature of the company's operations and sales trends.  Specifically, the complaint alleges that certain officers and directors of the company failed to disclose that Vitamin Shoppe's performance was being negatively impacted because of: (i) competition from discount on-line retailers; (ii) competitor GNC's new discount program; and (iii) declining same-store sales trends.  As a result of these false and misleading statements, Vitamin Shoppe's stock traded at artificially inflated prices during the Class Period, reaching a high of $65.93 per share on February 19, 2013, during which time company insiders sold more than $30 million of their company stock at inflated prices.    

Vitamin Shoppe Stock Price Drops on Slowdown in Revenue Growth

On February 25, 2013, the complaint alleges, Vitamin Shoppe issued financial results significantly below the lower than the strong forward guidance issued throughout the Class Period, revealing the Company's true business health.  On this news, Vitamin Shoppe's stock price dropped 18.76%, or $11.86 per share, to close at $51.36 per share.

If you purchased or otherwise acquired Vitamin Shoppe stock during the Class Period and wish to serve as lead plaintiff, you must act no later than July 8, 2013.  To discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003,, or via the shareholder information form on the firm's website. 

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to

Press release link:

Attorney Advertising. Past results do not guarantee a similar outcome.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.72 -0.31%
FB $100.81 1.10%
GOOG $689.58 1.00%
TSLA $151.16 2.10%
YHOO $27.03 -0.07%


Chart of I:DJI
DOW 15,971.44 -55.61 -0.35%
S&P 500 1,849.49 -3.95 -0.21%
NASDAQ 4,275.8220 -7.9310 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs